Estatísticas para COST EFFECTIVENESS OF ICATIBANT FOR HEREDITARY ANGIOEDEMA IN BRAZIL: CHALLENGES IN THE ECONOMIC EVALUATION OF ORPHAN DRUGS

Total visits

views
COST EFFECTIVENESS OF ICATIBANT FOR HEREDITARY ANGIOEDEMA IN BRAZIL: CHALLENGES IN THE ECONOMIC EVALUATION OF ORPHAN DRUGS 0